Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Evaluating Ga-68 DOTATATE images: SUVmax vs Krenning score

Susie Forbes, Yaser Baghdadi, Fauziya Parkar, Tony Abraham and Charito Love
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1535;
Susie Forbes
2Radiology Montefiore Medical Center Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaser Baghdadi
2Radiology Montefiore Medical Center Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fauziya Parkar
2Radiology Montefiore Medical Center Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Abraham
2Radiology Montefiore Medical Center Bronx NY United States
1Radiology Albert Einstein College of Medicine Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charito Love
2Radiology Montefiore Medical Center Bronx NY United States
1Radiology Albert Einstein College of Medicine Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1535

Introduction: Radionuclide imaging of neuroendocrine tumors (NET) relies on detection of somatostatin receptors expressed by these tumors. When evaluating activity, Krenning score system has been established in the past for the single photon emitter In-111 Octreotide. Availability of Ga-68 DOTATATE PET/CT (Ga68) has allowed better visualization of these tumors and semiquantitation of receptors with SUVmax (SUV). A number of clinical trials on therapeutic agents for patients with NET continue to utilize certain Krenning score (#II) for patient inclusion into the study. We sought to compare the performance of Krenning score system versus SUV in evaluation of NET lesions.

Methods: A consecutive series of 26 patients (nineteen females and seven males) at a median age of 56 years (IQR: 42-62) underwent Ga68 for evaluating known or suspected neuroendocrine tumors (NET). The primary site of malignancy included pancreas (ten patients, 38%), bowel (eight patients, 31%), lung (one patient) and unknown (seven patients, 27%). SUVs and Krenning scores were used to evaluate all lesions. For Krenning scoring, lesions were visually compared to liver activity. Lesions with very mild activity were scored Krenning I, those with uptake nearly equal to the liver were scored as Krenning score II, greater than the liver and less than the spleen as III, and greater than the spleen as IV (1). The continuous variables expressed as medians with interquartile ranges and categorical variables as proportions. Continuous variables among Krenning groups were compared using the non-parametric Kruskal-Wallis test.

Results: Of the 26 patients, 19 patients (73%) had metastases while seven (27%) did not. Among the 19 patients, there were 26 sites (39%) stratified as Krenning class VI, 24 (36%) as III, 10 (15%) as II, and seven (10%) as I. Metastases sites had median SUVmax of 22.6 (IQR: 18-39) for Krenning VI, 10.7 (IQR: 8-15) for Krenning III, four (IQR: 3-7) for Krenning II, and 2.8 (IQR: 2-5) for Krenning I. Using Kruskal-Wallis test, there were significant differences between the SUVmax medians for the metastases sites with 23 (IQR: 18-39) for IV, 11 (IQR: 3-7) for III, and four (IQR: 3-7) I and II classes (p<0.001).

Conclusions: In this patient population,Krenning scores and measured SUV provided useful tool in our evaluation of NET. There was a trend of greater SUV values with higher Krenning scores. Additional research with larger cohort of patients is required to further define utility of Krenning criteria now that SUV measurement can easily be obtained with Ga-68. Reference:(1) Semin Nucl Med. 2002 Apr;32(2):84-91. Somatostatin receptor imaging. Kwekkeboom DJ1, Krenning EP.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating Ga-68 DOTATATE images: SUVmax vs Krenning score
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluating Ga-68 DOTATATE images: SUVmax vs Krenning score
Susie Forbes, Yaser Baghdadi, Fauziya Parkar, Tony Abraham, Charito Love
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1535;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluating Ga-68 DOTATATE images: SUVmax vs Krenning score
Susie Forbes, Yaser Baghdadi, Fauziya Parkar, Tony Abraham, Charito Love
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1535;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients
  • Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of semi-quantitative evaluation using SUV applying 2 phase-imaging of IMP SPECT for diagnosis of choroidal melanoma.
  • Surveillance Imaging of Laryngeal Cancer - Does FDG PET/CT Impact Survival?
Show more Oncology: Clinical Therapy and Diagnosis

Endocrinology (Clinical Therapy) Posters

  • External Radiation Exposure Rates After [177Lu]DOTA-Octreotate Therapy
  • Feasibility of post-therapy quantitative Lu-177-DOTATATE SPECT/CT in patients with metastatic neuroendocrine tumor for evaluation of response to treatment: Comparison with Ga68-DOTATATE-PET/CT
  • Predictors of outcome in patients with neuroendocrine neoplasm (NEN) undergoing FDG PET prior to PRRT
Show more Endocrinology (Clinical Therapy) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire